For more information or confidential assistance
Call 800-306-3180

Growing Abilify Litigation Now Centralized

court house
As more lawsuits continue to be filed against manufacturers of the antipsychotic drug Abilify, the growing litigation has now been centralized into multidistrict litigation. The decision was made to streamline early trial proceedings as more plaintiffs file complaints claiming the drug has led to uncontrollable... Read More

Fifth Risperdal Case Ends in Settlement before Trial

Risperdal Lawsuit
The most recent Risperdal lawsuit slated to go before a jury ended in a settlement before the trial even began. Risperdal manufacturer Johnson & Johnson agreed to settle the case for an undisclosed amount, possibly avoiding another massive judgement that has characterized recent Risperdal trials. The latest case, which was... Read More

Taxotere Plaintiffs Prevail in Request for MDL

Pursuant to an October 10 transfer order filed by the United States Judicial Panel on Multidistrict Litigation, cases involving claims against the maker of breast cancer drug Taxotere have been consolidated under the supervision of U.S. District Judge Lance Africk in the Eastern District of... Read More